What is the recommended oral dose of trimethoprim (TMP) sulfamethoxazole (SMX) for an adult patient with a serious urinary tract infection (UTI) and presumed normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trimethoprim-Sulfamethoxazole Dosing for Serious UTI in Adults

For a serious urinary tract infection (complicated UTI or pyelonephritis) in an adult with normal renal function, the recommended oral dose is trimethoprim-sulfamethoxazole 160/800 mg (one double-strength tablet) twice daily for 14 days. 1

Standard Dosing for Serious UTI

  • The FDA-approved dosing for urinary tract infections is one double-strength tablet (160 mg trimethoprim/800 mg sulfamethoxazole) every 12 hours for 10-14 days. 1

  • For uncomplicated pyelonephritis specifically, guidelines recommend 14 days of therapy at this same dose (one double-strength tablet twice daily), but only after confirming susceptibility. 2

  • This dosing achieves clinical cure rates of 90-100% when organisms are susceptible. 3, 2

Critical Distinction: Serious vs. Uncomplicated UTI

  • The 3-day regimen (one double-strength tablet twice daily for 3 days) is only appropriate for uncomplicated cystitis in women—never for serious infections, pyelonephritis, or UTIs in men. 3, 2

  • Men with UTI require a minimum of 7 days of therapy at the same dose (one double-strength tablet twice daily), as the 3-day regimen leads to treatment failure. 3, 2

Renal Function Adjustments

  • Standard dose (one double-strength tablet twice daily) is appropriate when creatinine clearance is >30 mL/min. 1

  • When creatinine clearance is 15-30 mL/min, reduce to half the usual dose (one single-strength tablet twice daily or half of a double-strength tablet twice daily). 4, 1

  • Avoid trimethoprim-sulfamethoxazole entirely when creatinine clearance is <15 mL/min. 4, 1

When to Avoid Empiric Use

  • Do not use trimethoprim-sulfamethoxazole empirically when local E. coli resistance exceeds 20%, as efficacy plummets from 84% to only 41-54% when organisms are resistant. 2

  • Avoid in patients who used trimethoprim-sulfamethoxazole in the preceding 3-6 months or traveled outside the United States recently, as these factors predict resistance. 2

  • For serious infections like pyelonephritis, consider initial parenteral therapy with ceftriaxone or an aminoglycoside first if susceptibility is unknown, rather than giving empiric oral therapy. 3

Alternative Agents for Serious UTI

  • Fluoroquinolones (ciprofloxacin 500 mg twice daily for 7 days) are preferred alternatives for pyelonephritis when trimethoprim-sulfamethoxazole cannot be used, but only if local resistance is <10%. 3, 2

  • Nitrofurantoin and fosfomycin are not appropriate for serious UTI or pyelonephritis—they are reserved for uncomplicated cystitis only. 3, 2

Common Pitfalls to Avoid

  • Never use the 3-day regimen for serious infections—this is the most common dosing error and leads to treatment failure. 3

  • Always dose-adjust when creatinine clearance is <30 mL/min to prevent hyperkalemia, bone marrow suppression, and crystalluria. 3

  • Ensure adequate hydration (minimum 1.5 liters daily) to prevent crystalluria during therapy. 5

  • Monitor baseline potassium levels, as trimethoprim blocks potassium excretion and causes hyperkalemia. 5

References

Guideline

Uncomplicated Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Trimethoprim/Sulfamethoxazole Dosing for UTI with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Trimethoprim-Sulfamethoxazole Dosing for UTI in the Elderly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.